세계의 심방세동 기기 시장 규모 조사와 예측 : 제품별, 최종사용별, 지역별 분석(2022-2029년)

Global Atrial Fibrillation Devices Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. The most prevalent cardiac arrhythmia in contemporary clinical practice, atrial fibrillation (AF), is estimated to affect roughly 2% of the world's population. As the population ages and patients with structural heart problems become more prevalent, atrial fibrillation's incidence is continuously growing. Major risk factors for the syndrome include several age-related illnesses, high blood pressure, congenital heart disease, excessive alcohol intake, and underlying heart and lung conditions. Growing advancements in atrial fibrillation devices, rising global incidence of cardiovascular disorders, and rising prevalence of secondary health conditions are key factors anticipated to drive market revenue growth over the forecast period. Atrial fibrillation is becoming increasingly common in older people and the general population due to unhealthy lifestyles and rising prevalence of secondary health conditions.

In 2050, 1 in 6 of the world's population will be over 65, up from 1 in 11 in 2019, predicts World Population Prospects 2019 (United Nations, 2019). In 2019, there were 703 million people worldwide who were 65 or older. In 2050, it is expected that there will be 1.5 billion senior people. In the worldwide, the percentage of people 65 and older rose from 6% in 1990 to 9% in 2019. On the other side, cardiovascular disease claims one life in the United States every 34 seconds. In the United States, heart disease claimed the lives of almost 697,000 people in 2020, accounting for 1 in 5 fatalities. However, high price of devices stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Atrial Fibrillation Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. A growing government investment to speed the creation of a strong healthcare infrastructure in North America is expected to account for the largest market share. However, due to accelerated expenditures in healthcare infrastructure and rising demand for atrial fibrillation devices, Asia Pacific is expected to register the highest revenue throughout the forecasted years.

Major market players included in this report are:

Boston Scientific Corporation

AtriCure, Inc.

Abbott Laboratories

BIOTRONIK

CardioFocus, Inc.

Hansen Medical

Johnson and Johnson

Siemens Healthineers

Medtronic plc

Stereotaxis, Inc.

Recent Developments in the Market:

• Ascension Sacred Heart Bay launched a novel treatment in October 2021 to treat patients with heart problems by inserting a tiny device into the heart. Patients with atrial fibrillation that is not driven on by heart valve issues may have a reduction in their risk of stroke as a result of the new therapy.
• Match Health Academy, an online learning platform, introduced three online video-based courses in September 2021 to inform patients and their families about atrial fibrillation and assist them in better managing it. The courses will provide in-depth information on how to treat the ailment and have been created so that patients may easily grasp the situation.

Global Atrial Fibrillation Devices Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product, End-use, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

EP Ablation Catheters

EP Diagnostic Catheters

Mapping and Recording Systems

Cardiac Monitors or Implantable Loop Recorder

Access Devices

Intracardiac Echocardiography (ICE)

Left Atrial Appendage (LAA) Closure Devices

By End-use:

Hospitals

Cardiac Centers

Ambulatory Surgical Centers

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Atrial Fibrillation Devices Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Atrial Fibrillation Devices Market, by Product, 2019-2029 (USD Billion)
  • 1.2.3. Atrial Fibrillation Devices Market, by End-use, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Atrial Fibrillation Devices Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Atrial Fibrillation Devices Market Dynamics

• 3.1. Atrial Fibrillation Devices Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rising geriatric population
    • 3.1.1.2. Increasing prevalence of cardiovascular diseases
  • 3.1.2. Market Challenges
    • 3.1.2.1. High price of devices
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising adoption rate of advance technologies
    • 3.1.3.2. Rising number of multi-specialty hospitals

Chapter 4. Global Atrial Fibrillation Devices Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Atrial Fibrillation Devices Market, by Product

• 6.1. Market Snapshot
• 6.2. Global Atrial Fibrillation Devices Market by Product, Performance - Potential Analysis
• 6.3. Global Atrial Fibrillation Devices Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
• 6.4. Atrial Fibrillation Devices Market, Sub Segment Analysis
  • 6.4.1. EP Ablation Catheters
  • 6.4.2. EP Diagnostic Catheters
  • 6.4.3. Mapping and Recording Systems
  • 6.4.4. Cardiac Monitors or Implantable Loop Recorder
  • 6.4.5. Access Devices
  • 6.4.6. Intracardiac Echocardiography (ICE)
  • 6.4.7. Left Atrial Appendage (LAA) Closure Devices

Chapter 7. Global Atrial Fibrillation Devices Market, by End-use

• 7.1. Market Snapshot
• 7.2. Global Atrial Fibrillation Devices Market by End-use, Performance - Potential Analysis
• 7.3. Global Atrial Fibrillation Devices Market Estimates & Forecasts by End-use 2019-2029 (USD Billion)
• 7.4. Atrial Fibrillation Devices Market, Sub Segment Analysis
  • 7.4.1. Hospitals
  • 7.4.2. Cardiac Centers
  • 7.4.3. Ambulatory Surgical Centers
  • 7.4.4. Others

Chapter 8. Global Atrial Fibrillation Devices Market, Regional Analysis

• 8.1. Atrial Fibrillation Devices Market, Regional Market Snapshot
• 8.2. North America Atrial Fibrillation Devices Market
  • 8.2.1. U.S. Atrial Fibrillation Devices Market
    • 8.2.1.1. Product breakdown estimates & forecasts, 2019-2029
    • 8.2.1.2. End-use breakdown estimates & forecasts, 2019-2029
  • 8.2.2. Canada Atrial Fibrillation Devices Market
• 8.3. Europe Atrial Fibrillation Devices Market Snapshot
  • 8.3.1. U.K. Atrial Fibrillation Devices Market
  • 8.3.2. Germany Atrial Fibrillation Devices Market
  • 8.3.3. France Atrial Fibrillation Devices Market
  • 8.3.4. Spain Atrial Fibrillation Devices Market
  • 8.3.5. Italy Atrial Fibrillation Devices Market
  • 8.3.6. Rest of Europe Atrial Fibrillation Devices Market
• 8.4. Asia-Pacific Atrial Fibrillation Devices Market Snapshot
  • 8.4.1. China Atrial Fibrillation Devices Market
  • 8.4.2. India Atrial Fibrillation Devices Market
  • 8.4.3. Japan Atrial Fibrillation Devices Market
  • 8.4.4. Australia Atrial Fibrillation Devices Market
  • 8.4.5. South Korea Atrial Fibrillation Devices Market
  • 8.4.6. Rest of Asia Pacific Atrial Fibrillation Devices Market
• 8.5. Latin America Atrial Fibrillation Devices Market Snapshot
  • 8.5.1. Brazil Atrial Fibrillation Devices Market
  • 8.5.2. Mexico Atrial Fibrillation Devices Market
• 8.6. Rest of The World Atrial Fibrillation Devices Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Boston Scientific Corporation
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. AtriCure, Inc.
  • 9.2.3. Abbott Laboratories
  • 9.2.4. BIOTRONIK
  • 9.2.5. CardioFocus, Inc.
  • 9.2.6. Hansen Medical
  • 9.2.7. Johnson and Johnson
  • 9.2.8. Siemens Healthineers
  • 9.2.9. Medtronic plc
  • 9.2.10. Stereotaxis, Inc.

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption